Escape Pilot Purgatory. Go From Pilot-to-Paid.
That’s why we built the Pilot-to-Paid Pathway™ — a clear, structured way for MedTech innovators to move from clinical proof to scalable revenue.
Every engagement begins with a Go-To-Market Diagnostic, where we pinpoint what’s blocking adoption and map the fastest path forward.
The Pilot-to-Paid Pathway™
3 Phases. 3 Levers. Engineered to turn clinical proof into scalable revenue.
At its core is our Pilot-to-Paid blueprint — a commercialization system that transforms pilots into contracts, VAC approvals, and reimbursement-aligned adoption. Each phase builds on the last: aligning the story and coalition, engineering pilots that convert, and building the engine that scales adoption across systems.
.png)
Sharpen your narrative and map every stakeholder who matters. Most MedTech stories resonate clinically but fall flat with finance, supply chain, IT, and payers. We translate your value into a unified narrative that lands across the buying group and arm champions with concise proof that wins consensus.
Pilots can’t just prove clinical value, they need to generate decision-grade evidence for VAC approval, reimbursement traction, and budget alignment. We design pilots as sales processes, define success triggers upfront, and package results into approval-ready dossiers that convert interest into contracts.
Early proof isn’t enough without the infrastructure to scale. We codify sales playbooks, stand up dashboards, equip your team with proof libraries, and build reimbursement and GPO strategies. The result: a growth engine that expands adoption across sites and signals investor-ready traction.